Name: 2nd Annual MarketsandMarkets ImmunoBio Series
Start: 2024-10-14
End: 2024-10-15
Location: Freiburg, Germany

Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg, Germany.

Dive deep into the convergence of biomarkers and immuno-oncology at our flagship conference, where industry pioneers, thought leaders, and experts converge to drive innovation in healthcare and biotechnology. This transformative event offers a dynamic platform for collaboration, knowledge exchange, and exploration of cutting-edge research and applications in personalized medicine and cancer treatment.

Esteemed keynote speakers will deliver groundbreaking insights into the latest developments and prospects of biomarker research and immuno-oncology, setting the stage for impactful discussions and networking opportunities. With over 40 speakers from leading pharma, biopharma, and biotech companies worldwide, attendees will gain invaluable insights into the development of ADCs, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors, and Cellular Therapy, shaping the future of immuno-oncology.

Experience immersive sessions, brainstorming panel discussions, and case studies that delve into the challenges and solutions in biomarker and immuno-oncology research and development. From oncology to non-oncology indications such as Alzheimer’s and Parkinson’s, discover the latest advancements revolutionizing personalized medicine pipelines.

Explore the frontier of healthcare innovation and collaboration at the 2nd Annual MarketsandMarkets ImmunoBio Series, where innovation meets collaboration to shape the future of healthcare and biotechnology. Join us for this transformative event and make a marked difference in patient outcomes.

Preclinical and Translational Immuno-Oncology Developments
Biomarker Discovery Techniques: Explore novel strategies, including genomics, proteomics, metabolomics, and bioinformatics, to identify cutting-edge biomarkers in oncology.
Precision Medicine Tailoring: Understand the pivotal role of biomarkers in customizing immunotherapy for individual patients, enhancing efficacy, and minimizing side effects.
Personalizing Cancer Treatment- Challenges and Opportunities
Rigorous Biomarker Validation: Learn strategies and overcome challenges in validating biomarkers for clinical use, ensuring robust and reliable results.
Bioinformatics and AI Analysis: Attend sessions on biomarker data analysis, employing machine learning and artificial intelligence approaches for comprehensive insights.
Biomarker-Based Cancer Diagnostics Development: Gain insights into the development and commercialization of diagnostic tests and platforms based on biomarkers.
Next Gen Antibodies and Targeted Therapies
Immune Checkpoint Inhibitors and Combination Therapies
Tumor Microenvironment and Cancer Biomarkers
CAR-T cell therapy, T Cell Therapy, Adoptive Cell Therapy
Cancer Vaccines and Cancer Microbiome
Collaboration for Advancement: Explore sessions on fostering collaboration among academia, industry, and government agencies to drive biomarker research forward.

Cutting-Edge Insights: Access the latest advancements in biomarker discovery, precision medicine, and clinical applications spanning cancer and immunology.
Innovative Immunotherapy: Dive into immune-oncology projects, exploring antibodies, cellular therapy, and immune checkpoint research. Contribute to interactive discussions, share your work, and stay updated on cutting-edge technologies and platforms.
Networking and Collaboration: Connect with industry leaders, researchers, and peers. Foster collaborations, engage in thought-provoking discussions, and explore partnership opportunities.
Professional Development: Enhance your skills with workshops on cancer biomarker data analysis, machine learning, and artificial intelligence applications. Learn best practices and methodologies for biomarker and IO research.
Practical Applications: Discover how research translates into real-world applications. Explore exhibitor showcases, demonstrations, and case studies, gaining insights into the latest tools and technologies.
Personal and Industry Growth: Step out of your comfort zone, engage in interactive roundtables, and contribute to key discussions. Elevate your personal and professional growth within the dynamic fields of biomarker research and immunotherapy.

Engage in groundbreaking research, expand your network, and drive innovation at the Immunobio Series, where science meets collaboration.

CONFERENCE AGENDA

Registration	08:15 - 08:50
Welcome note from MarketsandMarkets	08:50 - 08:55
Opening Remarks from the Chairperson	08:55 - 09:00
PRE-CLINICAL AND TRANSLATIONAL IO & IMMUNE CHECKPOINT BLOCKADES
Keynote Presentation - Reserved Slot for Platinum Sponsor	09:00 - 09:30
Innovative Preclinical Models for Investigating Tumor-Immune Interactions	09:30 - 10:00
Reserved Slot for Gold Sponsor	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:15
Reserved Slot for Silver Sponsor	11:15 - 11:45
Translational approach in developing right IO therapy	11:45 - 12:15
Oncolytic viruses in the era of Checkpoint Blockade	12:15 - 12:45
Challenges and Opportunities in Validating Preclinical Models for Immuno-Oncology Drug Development	12:45 - 13:15
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:15 - 14:15
ADVANCEMENTS IN ANTIBODY AND CELL THERAPY
Solution Provider Presentation	14:15 - 14:45
Novel Bispecific PD-1 antibody therapeutic approach in solid tumours	14:45 - 15:15
Combination Strategies to Overcome Resistance to Anti-PD-1/PD-L1 Therapies	15:15 - 15:45
Development of new generation DNA vaccines and novel mRNA-based Immunotherapy Vaccines	15:30 - 17:00
Afternoon Refreshments and Poster Presentation \| One-to-One Networking Meetings	15:45 - 14:30
Panel Discussion: Immunotherapy Frontiers: Integrating Precision Immunology, Cancer Microbiome, and CAR-T Therapies for Tailored Patient Care	17:00 - 17:30
Closing Remarks from the Chairperson	17:00 - 17:00

Registration	08:15 - 08:50
Welcome note from MarketsandMarkets	08:50 - 08:55
Opening Remarks from the Chairperson	08:55 - 09:00
ROLE OF CANCER BIOMARKERS IN PERSONALIZED MEDICINE
Keynote Presentation - Reserved for Platinum Sponsor	09:00 - 09:30
Unlocking the Potential of Multi-omics: Bridging Biomarkers and Personalized Therapies	09:30 - 10:00
Solution Provider Presentation-Reserved for Gold Sponsor	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:15
Solution Provider Presentation-Reserved for Silver Sponsor	11:15 - 11:45
Assessing the Safety and Efficacy of ctDNA in Augmenting Immunotherapy Interventions	11:15 - 12:45
Functional biomarker assay development for cancer treatment	11:45 - 12:15
Advancements in Imaging Biomarkers for Cancer Diagnosis and Monitoring	12:45 - 13:15
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:15 - 14:15
OPTIMIZING PATIENT CARE AND THERAPEUTIC ASSESSMENT LEVERAGING IO MARKERS
Role of Biomarkers in Clinical Trials: Enhancing Patient Monitoring and Therapeutic Evaluation	14:15 - 14:45
Panel Discussion: Opportunities and Challenges in Biomarker Testing: Comparing Oncology and Non-Oncology Perspectives	14:45 - 15:15
Closing Remarks from the Chairperson	15:15 - 15:15